Queen’s hosts Conference on Trauma Focused CPTSD | News | Queen's University Belfast
Archived: 2026-04-23 17:24
Queen’s hosts Conference on Trauma Focused CPTSD | News | Queen's University Belfast
Share
Facebook
Linkedin
Email
All News
2026
2025
2024
Queen’s hosts Conference on Trauma Focused CPTSD
2 April, 2026
The recently established Centre for Mental Health & Trauma (CMHaT) at Queen’s, in partnership with the University of Oxford, hosted the ‘Trauma Focused CPTSD’ conference to present and discuss the UK-wide Complex PTSD (CPTSD) trial findings.
Pictured L-R are: Dr Kevin Dyer; Dr Deborah Lee; Dr Michael Duffy; Professor Robin Hickey; Heather Stevens; and Dr Ciaran Mulholland.
Funded by a £2 million award from the
National Institute for Health and Care Research (NIHR)
, the four-year trial was led by Professor Anke Ehlers, from the
University of Oxford
, and
Dr Michael Duffy
, Director of the CMHaT and from the
School of Social Sciences, Education and Social Work
at Queen’s.
The conference was attended by Health and Social Care (HSC) trial therapists, Trust mental health managers, the trial patient and public involvement group and clients,
Regional Trauma Network
leads, and
Queen’s
staff and students.
Complex
post-traumatic stress disorder
(CPTSD) is a distressing and disabling mental disorder. It is common among people who have experienced prolonged or repeated severe traumas, such as childhood abuse or multiple experiences of civil conflict but can also occur after other traumas. Trauma focused Cognitive Behavioural Therapy (CBT) is recommended as first-line treatments for PTSD, however, there is limited evidence about which therapies or treatments work best for Complex PTSD.
While many clinicians and researchers advocate a phased approach to treating CPTSD, there is limited empirical evidence that phased interventions are more effective or acceptable than standard trauma-focused interventions. The aim of the study was to investigate whether a phased version of trauma-focused cognitive therapy (TF-CT) for PTSD is superior to standard TF-CT in the treatment of CPTSD.
The conference was opened by Professor Robin Hickey, Associate Pro-Vice-Chancellor for the Faculty of Arts, Humanities, and Social Sciences at Queen’s. He said:
“We at Queen’s are very proud to have co-led a study of this scale that can advance knowledge and improve therapies for such conditions. Queen’s places great importance on our collaboration with colleagues in Oxford and the NHS/HSC Trusts. Such partnerships enable vital research work of this complexity to be carried out, and secure the grants necessary to undertake it. The University wishes to record our thanks to NIHR for awarding £2 million to Oxford and Queen’s for this study.”
Heather Stevens, Director of Mental Health at the Department of Health commented: “
At the Department of Health we are very interested in the trial findings and how this study can help us to implement the objectives of the new Mental Health Strategy. The cost of mental illness is huge in both human and economic terms. We encourage such high-quality research that can enhance treatments and improve patient outcomes.”
During the conference, co-leads in the trial, Dr Kevin Dyer and Dr Ciaran Mulholland from Queen’s, reflected on the importance of such studies to develop the evidence base for treatments that work in our mental health services, and of the impact of trauma-related conditions in Northern Ireland due to the enduring legacy of our recent conflict.
Dr Michael Duffy said:
“Such a study design, involving 10 sites across England and Northern Ireland presents many challenges and I want to thank and congratulate all involved in delivering the trial to such high standards. The study has attracted a lot of international interest, and we plan to share the findings widely over the next year.”
Further contributions were made by Dr Deborah Lee, Berkshire Healthcare NHS Foundation Trust, supervisor for the phased arm, and Mr Brendan Armstrong from Queen’s, supervisor for the non-phased arm, who presented on the challenges but also the potential for enhancing therapist knowledge and skills in a real-world trial.
And finally, trial participant Ken Brown, addressed the conference, explaining how the trial had changed his life for the better. Read more about Ken’s story here:
https://www.qub.ac.uk/about/civic-engagement/180/finding-light-after-darkness.html
Featured Expert
Dr Michael Duffy
Senior Lecturer
Centre for Evidence and Social Innovation (CESI), School of Social Sciences, Education and Social Work (SSESW), The Institute for Global Peace, Security and Justice
Dr Ciaran Mulholland
Clinical Senior Lecturer
School of Medicine, Dentistry and Biomedical Sciences (MDBS), The Institute for Global Peace, Security and Justice
Media
Media enquiries to Zara McBrearty on email:
z.mcbrearty@qub.ac.uk
Share
Latest News
Queen’s researcher first in UK to win international award
23 April, 2026
Scientists unlock new way to boost extreme light - proving Einstein’s theory right
23 April, 2026
New all-island radiotherapy trial aims to reduce prostate cancer treatment side effects
22 April, 2026
First UK study to map higher radon levels with increased lung cancer risk
20 April, 2026
Queen’s hosts Conference on Trauma Focused CPTSD
2 April, 2026
Close Search
Share
All News
2026
2025
2024
Queen’s hosts Conference on Trauma Focused CPTSD
2 April, 2026
The recently established Centre for Mental Health & Trauma (CMHaT) at Queen’s, in partnership with the University of Oxford, hosted the ‘Trauma Focused CPTSD’ conference to present and discuss the UK-wide Complex PTSD (CPTSD) trial findings.
Pictured L-R are: Dr Kevin Dyer; Dr Deborah Lee; Dr Michael Duffy; Professor Robin Hickey; Heather Stevens; and Dr Ciaran Mulholland.
Funded by a £2 million award from the
National Institute for Health and Care Research (NIHR)
, the four-year trial was led by Professor Anke Ehlers, from the
University of Oxford
, and
Dr Michael Duffy
, Director of the CMHaT and from the
School of Social Sciences, Education and Social Work
at Queen’s.
The conference was attended by Health and Social Care (HSC) trial therapists, Trust mental health managers, the trial patient and public involvement group and clients,
Regional Trauma Network
leads, and
Queen’s
staff and students.
Complex
post-traumatic stress disorder
(CPTSD) is a distressing and disabling mental disorder. It is common among people who have experienced prolonged or repeated severe traumas, such as childhood abuse or multiple experiences of civil conflict but can also occur after other traumas. Trauma focused Cognitive Behavioural Therapy (CBT) is recommended as first-line treatments for PTSD, however, there is limited evidence about which therapies or treatments work best for Complex PTSD.
While many clinicians and researchers advocate a phased approach to treating CPTSD, there is limited empirical evidence that phased interventions are more effective or acceptable than standard trauma-focused interventions. The aim of the study was to investigate whether a phased version of trauma-focused cognitive therapy (TF-CT) for PTSD is superior to standard TF-CT in the treatment of CPTSD.
The conference was opened by Professor Robin Hickey, Associate Pro-Vice-Chancellor for the Faculty of Arts, Humanities, and Social Sciences at Queen’s. He said:
“We at Queen’s are very proud to have co-led a study of this scale that can advance knowledge and improve therapies for such conditions. Queen’s places great importance on our collaboration with colleagues in Oxford and the NHS/HSC Trusts. Such partnerships enable vital research work of this complexity to be carried out, and secure the grants necessary to undertake it. The University wishes to record our thanks to NIHR for awarding £2 million to Oxford and Queen’s for this study.”
Heather Stevens, Director of Mental Health at the Department of Health commented: “
At the Department of Health we are very interested in the trial findings and how this study can help us to implement the objectives of the new Mental Health Strategy. The cost of mental illness is huge in both human and economic terms. We encourage such high-quality research that can enhance treatments and improve patient outcomes.”
During the conference, co-leads in the trial, Dr Kevin Dyer and Dr Ciaran Mulholland from Queen’s, reflected on the importance of such studies to develop the evidence base for treatments that work in our mental health services, and of the impact of trauma-related conditions in Northern Ireland due to the enduring legacy of our recent conflict.
Dr Michael Duffy said:
“Such a study design, involving 10 sites across England and Northern Ireland presents many challenges and I want to thank and congratulate all involved in delivering the trial to such high standards. The study has attracted a lot of international interest, and we plan to share the findings widely over the next year.”
Further contributions were made by Dr Deborah Lee, Berkshire Healthcare NHS Foundation Trust, supervisor for the phased arm, and Mr Brendan Armstrong from Queen’s, supervisor for the non-phased arm, who presented on the challenges but also the potential for enhancing therapist knowledge and skills in a real-world trial.
And finally, trial participant Ken Brown, addressed the conference, explaining how the trial had changed his life for the better. Read more about Ken’s story here:
https://www.qub.ac.uk/about/civic-engagement/180/finding-light-after-darkness.html
Featured Expert
Dr Michael Duffy
Senior Lecturer
Centre for Evidence and Social Innovation (CESI), School of Social Sciences, Education and Social Work (SSESW), The Institute for Global Peace, Security and Justice
Dr Ciaran Mulholland
Clinical Senior Lecturer
School of Medicine, Dentistry and Biomedical Sciences (MDBS), The Institute for Global Peace, Security and Justice
Media
Media enquiries to Zara McBrearty on email:
z.mcbrearty@qub.ac.uk
Share
Latest News
Queen’s researcher first in UK to win international award
23 April, 2026
Scientists unlock new way to boost extreme light - proving Einstein’s theory right
23 April, 2026
New all-island radiotherapy trial aims to reduce prostate cancer treatment side effects
22 April, 2026
First UK study to map higher radon levels with increased lung cancer risk
20 April, 2026
Queen’s hosts Conference on Trauma Focused CPTSD
2 April, 2026
Close Search